apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Clinical determinants of long-term survival in metastatic uveal melanoma (2021) Koch E, Petzold A, Wessely A, Dippel E, Erdmann M, Heinzerling L, Hohberger B, et al. Journal article Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008 (2021) Eigentler T, Heinzerling L, Krauss J, Weishaupt C, Ochsenreither S, Lebbe C, Mohr P, et al. Conference contribution Checkpoint-Inhibition bei Tumorerkrankungen (2021) Ben Khaled N, Piseddu I, Boehmer DFR, Zierold S, Heinzerling L, Mayerle J, De Toni EN Journal article, Review article Spätfolgen nach Immuntherapie: Immunvermittelte Nebenwirkungen von Checkpointinhibitoren (2021) Duong SL, Zierold S, Kramer R, Reincke M, Kerl-French K, Boehmerle W, Pavel ME, et al. Journal article, Review article Inflammatory markers in autoimmunity induced by checkpoint inhibitors (2021) Husain B, Kirchberger M, Erdmann M, Schüpferling S, Abolhassani AR, Fröhlich W, Berking C, Heinzerling L Journal article Experiences of In-Patients with Skin Cancer in a German University Hospital Setting: A Cross-Sectional Survey (2021) Steeb T, Wessely A, Merkl H, Voskens C, Erdmann M, Heinzerling L, Berking C, Heppt M Journal article Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group (2021) Wessely A, Steeb T, Berking C, Schlaak M, Heppt M, Alter M, Bayerl C, et al. Journal article Dual mtor/dna-pk inhibitor cc-115 induces cell death in melanoma cells and has radiosensitizing potential (2020) Bürkel F, Jost T, Hecht M, Heinzerling L, Fietkau R, Distel L Journal article Author Correction: Non-professional phagocytosis: a general feature of normal tissue cells (Scientific Reports, (2019), 9, 1, (11875), 10.1038/s41598-019-48370-3) (2020) Seeberg J, Loibl M, Moser F, Schwegler M, Büttner-Herold M, Daniel C, Engel F, et al. Journal article, Erratum Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients (2020) Leiter U, Loquai C, Reinhardt L, Rafei-Shamsabadi D, Gutzmer R, Kaehler K, Heinzerling L, et al. Journal article